PORTABLE DIAGNOSTIC SYSTEMS INC

ROBBINSVILLE, NJ · Medtech · Private

Integrity-1 Analysis System, a microfluidics-based portable drug screening device that detects multiple drugs from oral fluid samples

Grants
$276K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$2.4M
2 awards · Health and Human S
#190 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · FY23. SBIR Topic 167 Phase I: Ultraportable Lab-on-a-chip Biosensor System For Rapid Postmortem Toxicology. Period Of Performance: 9/27/23-9/26/24$400,000
Federal grantDepartment of Health and Human Services · Phase I · Microfluidic immunoassay as a polysubstance oral fluid screening tool for law enforcement to rapidly identify recent drug use in traffic stops to reduce traffic fatalities and injuries.$275,766
Federal contractDepartment of Health and Human Services · FY25. SBIR Topic 167 Phase II: Ultraportable Lab-on-a-chip Biosensor System For Rapid Postmortem Toxicology. Period Of Performance: 9/01/25-8/31/27$2,000,000
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
187DILON TECHNOLOGIES INC$2.5M$22M
188Wenzel Spine, Inc.$2.5M$4.9M
189MICROMICS TECHNOLOGIES LLC$2.5M—
190PORTABLE DIAGNOSTIC SYSTEMS INC$2.4M—
191AVONEAUX MEDICAL INSTITUTE, LLC$2.4M—
192TETRAIMAGING LLC$2.4M—
193EARLYDIAGNOSTICS INC$2.4M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.